- Home
- ECBK vs PRE Comparison
ECBK vs PRE Comparison
Compare ECBK & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ECBK | PRE |
|---|---|---|
| Founded | 1919 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.5M | 131.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ECBK | PRE |
|---|---|---|
| Price | $17.25 | $15.79 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 10.9K | ★ 162.2K |
| Earning Date | 02-04-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.95 | N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | $29,860,000.00 | ★ $77,079,000.00 |
| Revenue This Year | N/A | $219.28 |
| Revenue Next Year | N/A | $124.38 |
| P/E Ratio | $21.56 | ★ N/A |
| Revenue Growth | 20.84 | ★ 201.54 |
| 52 Week Low | $12.56 | $3.10 |
| 52 Week High | $17.75 | $18.48 |
Technical Indicators
Market Signals| Indicator | ECBK | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 53.53 | 48.66 |
| Support Level | $17.25 | $14.66 |
| Resistance Level | $17.39 | $16.20 |
| Average True Range (ATR) | 0.15 | 0.89 |
| MACD | -0.02 | -0.18 |
| Stochastic Oscillator | 40.93 | 30.22 |
Price Performance
Historical ComparisonAbout ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.